Anushka Singh

Indian biochemist pioneering affordable insulin production to combat diabetes crisis in developing nations

Anushka Singh's Breakthrough

Dr. Anushka Singh, a 34-year-old biochemist from India, developed the world's first low-cost microbial insulin production method in 2020. Her patent-pending process reduces manufacturing costs by 80%, making life-saving insulin accessible to millions in low-income countries. This innovation was highlighted in Nature's 2022 Health Tech Issue.

Global Impact

By 2024, Singh's technology had enabled 12 countries to establish local insulin production facilities. In Bangladesh alone, this reduced diabetes mortality rates by 40% among low-income patients. Her non-profit LifeBlood Initiative has trained 2,000+ healthcare workers in biomanufacturing techniques.

Awards & Recognition

Recipient of the Bill & Melinda Gates Foundation Health Innovation Award (2023), Singh's work addresses systemic inequities in global healthcare. She is currently expanding her research to develop affordable treatments for hypertension and cardiovascular diseases.